Group 1 - The stock price of Canan Co. closed at 22.32 yuan on August 27, 2025, down by 1.60 yuan, a decrease of 6.69% from the previous trading day [1] - The trading volume on that day was 38,915 hands, with a transaction amount of 0.90 billion yuan, and a fluctuation of 7.23% [1] - Canan Co. reported a revenue of 1.58 billion yuan for the first half of 2025, a year-on-year decline of 18.54%, and a net profit attributable to shareholders of 9.37 million yuan, down 71.78% year-on-year [1] Group 2 - The company's subsidiary, Anna Medical, recently received a utility model patent certificate from the National Intellectual Property Administration for a "self-ejecting needle with a broken needle" [1] - The third meeting of the company's third board of directors approved several proposals [1] - On August 27, the net outflow of main funds was 474,200 yuan, with a cumulative net outflow of 5.36 million yuan over the past five days [1]

Core Viewpoint - The company announced that its wholly-owned subsidiary, Anna Medical, has received a patent certificate from the National Intellectual Property Administration for a utility model patent related to a "self-ejecting needle for broken needles" [1] Group 1 - The patent is a result of the company's independent research and development efforts [1] - The technology involved in the patent is related to the company's main business products [1] - The patent rights will take effect from the date of the authorization announcement [1]